Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bard continues cardiology sell-off:

This article was originally published in Clinica

Executive Summary

CR Bard is to make a further divestment in its cardiology sector with the sale of its global intra-aortic balloon catheter and pump business to Arrow International, of Reading, Pennsylvania, for $28 million in cash. Bard will retain around $3 million working capital. Last month, the company sold its global coronary catheter laboratory business to Arterial Vascular Engineering for $600 million (see Clinica No 816, p 1). Bard, of Murray Hill, New Jersey, says it will consider options for its remaining coronary vascular businesses over the next few months. Separately, Arrow has bought custom tubing manufacturer Medical Parameter, an $8 million turnover company based in Woburn, Massachusetts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083204

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel